161 related articles for article (PubMed ID: 18619055)
21. Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer.
Zaha DC; Lazăr E; Lăzureanu C
Rom J Morphol Embryol; 2010; 51(1):85-9. PubMed ID: 20191125
[TBL] [Abstract][Full Text] [Related]
22. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Mansell J; Monypenny IJ; Skene AI; Abram P; Carpenter R; Gattuso JM; Wilson CR; Angerson WJ; Doughty JC
Breast Cancer Res Treat; 2009 Sep; 117(1):91-8. PubMed ID: 19112615
[TBL] [Abstract][Full Text] [Related]
23. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
[TBL] [Abstract][Full Text] [Related]
24. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
27. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
28. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
[TBL] [Abstract][Full Text] [Related]
29. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
van Nes JG; Putter H; Julien JP; Tubiana-Hulin M; van de Vijver M; Bogaerts J; de Vos M; van de Velde CJ;
Breast Cancer Res Treat; 2009 May; 115(1):101-13. PubMed ID: 18484198
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary metastases of breast cancer. When is resection indicated?
Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
[TBL] [Abstract][Full Text] [Related]
31. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients.
Pálka I; Ormándi K; Gaál S; Boda K; Kahán Z
Acta Oncol; 2007; 46(8):1178-83. PubMed ID: 17851833
[TBL] [Abstract][Full Text] [Related]
32. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
[TBL] [Abstract][Full Text] [Related]
33. Patterns of recurrence and survival in breast cancer.
Navarrete Montalvo D; González M N; Montalvo V MT; Jiménez A A; Echiburú-Chau C; Calaf GM
Oncol Rep; 2008 Sep; 20(3):531-5. PubMed ID: 18695902
[TBL] [Abstract][Full Text] [Related]
34. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
35. p53 as a specific prognostic factor in triple-negative breast cancer.
Chae BJ; Bae JS; Lee A; Park WC; Seo YJ; Song BJ; Kim JS; Jung SS
Jpn J Clin Oncol; 2009 Apr; 39(4):217-24. PubMed ID: 19304743
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of basal-like subtype in triple-negative breast cancer.
Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
[TBL] [Abstract][Full Text] [Related]
37. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
38. The prognostic importance of triple negative breast carcinoma.
Mersin H; Yildirim E; Berberoglu U; Gülben K
Breast; 2008 Aug; 17(4):341-6. PubMed ID: 18450442
[TBL] [Abstract][Full Text] [Related]
39. Study of time-course changes in annual recurrence rates for breast cancer: data analysis of 2,209 patients for 10 years post-surgery.
Kimura M; Yanagita Y; Fujisawa T; Koida T
Breast Cancer Res Treat; 2007 Dec; 106(3):407-11. PubMed ID: 17268809
[TBL] [Abstract][Full Text] [Related]
40. Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness.
Tagliabue E; Agresti R; Casalini P; Mariani L; Carcangiu ML; Balsari A; Veronesi U; Ménard S
Eur J Cancer; 2006 May; 42(8):1057-61. PubMed ID: 16624551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
